Table 6.
Overall prevalence of HIV-1 drug resistance by drug group.
| DRMs | N out of 37 | Percentage, % |
|---|---|---|
| NRTI | 20 | 54 |
| NNRTI | 29 | 78 |
| PI | 1 | 3 |
| INSTI | 0 | 0 |
| NRTI and NNRTI | 20 | 54 |
| NRTI, NNRTI, and PI | 1 | 3 |
NNRTI, non-nucleoside reverse transcriptase inhibitors; NRTI, nucleoside reverse transcriptase inhibitors; PI, protease inhibitors; INSTI, integrase strand transfer inhibitors; DRMs, drug resistance mutations.